UBS raised the firm’s price target on Varonis (VRNS) to $60 from $55 and keeps a Buy rating on the shares. Varonis’s Q1 results provided conviction in a broad-based growth algorithm rather than an over-reliance on conversions, the analyst tells investors in a research note. The firm sees shares as attractively priced for high-teens growth and continued free cash flow upside.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRNS:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue